Aktie A2P91G JAGSONPAL PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jagsonpal Pharmaceuticals Limited

Aktien

A2P91G

INE048B01027

JAGSNPHARM

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 13:43:47 26.04.2024 		% 5 Tage % 1. Jan.
343,6 INR +3,06 % Intraday Chart für Jagsonpal Pharmaceuticals Limited +7,97 % -11,66 %
08.03. Jagsonpal Pharmaceuticals Limited bringt Queezy-ER® auf den Markt CI
02.02. Jagsonpal Pharmaceuticals Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Jagsonpal Pharmaceuticals Limited Launches Queezy-ER®
Jagsonpal Pharmaceuticals Limited Announces Chief Financial Officer Changes
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Jagsonpal Pharmaceuticals' Net Profit Soars in Fiscal Q1
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2023
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm and others completed the acquisition of 43.73% stake in Jagsonpal Pharmaceuticals Limited from Aresko Progressive Private Limited and Rajpal Singh Kochhar.
Jagsonpal Pharmaceuticals Limited Announces Appointment of Abhishek Joshi as Company Secretary and Compliance Officer
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Jagsonpal Pharmaceuticals Limited Announces Executive Changes
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme
Jagsonpal Pharmaceuticals : Reply to Clarification Sought
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Jagsonpal Pharmaceuticals : Appointment
Jagsonpal Pharmaceuticals Limited Announces Executive Changes
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm cancelled the acquisition of 26% stake in Jagsonpal Pharmaceuticals Limited.
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P91G Aktie
  4. Nachrichten Jagsonpal Pharmaceuticals Limited
  5. Andere Sprachen